Ligand validation:6O0O

F3Q: ~{N}-(4-hydroxyphenyl)-3-[6-[[(3~{S})-3-(morpholin-4-ylmethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]-1,3-benzodioxol-5-yl]-~{N}-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide

F3Q is a Ligand Of Interest in 6O0O designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6O0O_F3Q_A_201	57%	73%	0.147	0.923	0.47	0.56	1	2	0	0	100%	1
6O0O_F3Q_C_201	38%	73%	0.176	0.879	0.44	0.6	-	3	0	0	100%	1
6GL8_F3Q_A_301	76%	24%	0.085	0.919	1.41	1.67	11	14	2	0	100%	1
8VWZ_F3Q_A_301	85%	71%	0.081	0.946	0.54	0.58	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.